Citations

Clear

4207 citation(s) found for "Chen, Yu".

Body mass index at birth and early life and colorectal cancer: A two‐sample Mendelian randomization analysis in European and East Asian genetic similarity populations
Papadimitriou, Nikos , Jenab, Mazda, Moreno, Victor, Platz, Elizabeth A., Duijnhoven, Fränzel J.B. van , Pai, Rish K. , Phipps, Amanda I. , Peters, Ulrike , Hughes, David J , Papadimitriou, Nikos , Murphy, Neil , Chen, Zhishan , Brenner, Hermann , Kweon, Sun-Seog , Marchand, Loı̈c Le , Platz, Elizabeth A. , Cheng, Iona C. , Zheng, Wei , Hughes, David J.

Mayo Clinic

Pediatric Obesity | November 26, 2024 | Volume: 20 | Issue: 1 | Pages: No page available

10.1111/ijpo.13186 | PMID 39587448 Get It

SummaryBackgroundVarying obesogenic inherited predisposition in early to later life may differentially impact colorectal cancer (CRC) development. Previous Mendelian randomization (MR) studies, conducted in populations of European genetic similarity, have not observed any significant associations between early life body weight with CRC risk. However, it remains unclear whether body mass index (BMI) at different early lifetime points is causally related with CRC risk in both Europeans and East Asian populations.ObjectivesWe conducted a two‐sample MR study to investigate potential causal relationships between genetically predicted BMI during early life (birth to 8 years old) and at specific periods (birth, transient, early rise and late rise) and CRC risk.MethodsSummary data were obtained from genome‐wide association study (GWAS) of BMI in 28 681 children from the Norwegian Mother, Father and Child Cohort Study (MoBa) study and applied to CRC GWAS data from European and East Asian descent populations (102 893 cases and 485 083 non‐cases).ResultsThere were no significant associations observed between early life BMI and CRC risk in European or East Asian populations. The effect estimates were similar in European studies (odds ratio [OR] per a 1‐standard deviation [SD] increase: 1.01, 95% confidence interval [CI]: 0.95, 1.07) and in East Asians (OR per a 1‐SD increase: 1.02, 95% CI: 0.91, 1.14). Similar nonsignificant associations were found between time of BMI measurement during childhood and cancer‐site‐specific analyses.ConclusionsWe found little evidence of any associations between early life adiposity on later life CRC risk.
Natriuretic peptide levels and predicting risk of developing new diabetes mellitus and metabolic syndrome
Singh, Jasraj , Scott, Christopher G., Chen, Horng H. , Adel, Fadi W , Adel, Fadi

Mayo Clinic

Diabetes, Obesity and Metabolism | November 25, 2024 | Volume: 27 | Issue: 2 | Pages: 777-784

10.1111/dom.16073 | PMID 39587371 Get It

Abstract Aims Define the relationship between N‐terminal atrial natriuretic peptide (NT‐ANP) levels and incident metabolic syndrome and type 2 diabetes mellitus (‘metabolic disease’) in healthy adults and develop a risk prediction score. Materials and Methods Retrospective cohort study of Olmsted County Heart Function Study participants, a random sampling of county residents aged 45 years and older ( n = 2042). Clinical data were collected during enrolment between 1997 and 2000 and upon follow‐up 4 years later. Outcomes were followed for 8 years. We studied 715 subjects without metabolic disease at enrolment who completed follow‐up, assessing incident metabolic disease as the primary outcome. Youden's index was used to identify optimal cut‐points and develop the risk score. Results Upon multivariate analysis adjusting for age gender, HDL and triglycerides, higher baseline serum NT‐ANP levels were associated with a lower risk of metabolic disease (OR: 0.65, CI 0.49–0.85, p = 0.002). Higher baseline serum insulin and aldosterone levels were associated with higher risk of incident metabolic disease (OR: 2.04, CI 1.57–2.65, p < 0.001; OR: 1.43, CI 1.14–1.81, p = 0.002, respectively). Baseline serum NT‐ANP < 3337 pg/mL was 96.6% sensitive for future development of metabolic disease. A weighted score including all three biomarkers was 78.6% sensitive and 77.3% specific. Conclusions In healthy adults aged 45 years or older, higher baseline NT‐ANP levels are associated with a lower four‐year risk of developing metabolic disease. Serum NT‐ANP levels are a sensitive biomarker of future risk of metabolic disease and have screening utility when combined with insulin and aldosterone levels into a composite score.
Conformation-specific RNA aptamers for phenotypic distinction between normal von Willebrand factor and type 2B von Willebrand disease
Machha, Venkata R. , Moon‐Tasson, Laurie, Tange, Julie I, Santiago-Davis, Annyoceli, Pruthi, Rajiv K. , Chen, Dong , Maher, L. James , Auton, Matthew , Tischer, Alexander , Moon-Tasson, Laurie, Tange, Julie, Chen, Dong , III, Louis James Maher , Auton, Matthew , Tischer, Alexander

Mayo Clinic

NAR Molecular Medicine | November 24, 2024 | Volume: 1 | Issue: 4 | Pages: No page available

10.1093/narmme/ugae021 | PMID 39719968 Get It

Abstract The A1 domain in Von Willebrand Factor (VWF) initiates coagulation through binding to platelet glycoprotein GPIbα receptors. Von Willebrand Disease (VWD)-Mutations in A1 that either impair (type 2M) or enhance (type 2B) platelet adhesion to VWF can locally destabilize and even misfold the domain. We leveraged misfolding in the gain-of-function type 2B VWD phenotype as a target, distinct from the normal conformation. Two nuclease-resistant 2′-fluoropyrimidine RNA aptamers were selected to discriminate normal A1 domains from a type 2B V1314D A1 variant in a glycosylated A1A2A3 tri-domain VWF-fragment. Two aptamers, W9 and V1, were isolated that selectively recognize, bind, and inhibit the A1–GPIbα interaction with WT A1A2A3 and V1314D A1A2A3, respectively. These aptamers were tested against their respective recombinant targets, plasma VWF, VWF concentrates, and patient plasma with the heterozygous type 2B VWD R1306W variant using clinical assays, surface plasmon resonance and inhibition assays of platelet adhesion to recombinant A1 and A1A2A3 domains under shear stress. The specificity of W9 and V1 aptamers confirms that pathological conformations of VWD Type 2B proteins are different from normal VWF. The availability of aptamers that distinguish normal plasma-derived VWF from VWD suggests potential applicability in clinical diagnosis of severe gain-of-function phenotypes.
Acute Leukemias of Ambiguous Lineage With MDS‐Associated Mutations Show Similar Prognosis Compared to Acute Myeloid Leukemia With MDS‐Associated Mutations: A Study From the Bone Marrow Pathology Group
Kirtek, Timothy , Chen, Weina , Harris, Jaryse , Bagg, Adam , Foucar, Kathryn , Tam, Wayne , Orazi, Attilio , Hasserjian, Robert P. , Wang, Sa A. , Reichard, Kaaren K. , Symes, Emily , Zhang, Xinmin , Weinberg, Olga K. , Kirtek, Timothy J , Wang, Sa A , Shi, Min , Zhang, Xinmin , Arber, Daniel A , Orazi, Attilio , Hsi, Eric D. , Ng, David P. , George, Tracy I. , Arber, Daniel A.

Mayo Clinic

American Journal of Hematology | November 23, 2024 | Volume: 100 | Issue: 2 | Pages: 300-304

10.1002/ajh.27537 | PMID 39578955 Get It

Association of left atrial function with vascular brain injury: The Atherosclerosis Risk in Communities study
Wang, Wendy , Lutsey, Pamela L. , Reyes, Jorge L. , Mosley, Thomas H. , Johansen, Michelle C. , Alonso, Álvaro , Jack, Clifford R. , Solomon, Scott D. , Shah, Amil, Wasserman, Bruce A. , Shah, Amil M. , Johansen, Michelle C , Jack, Clifford R , Alonso, Alvaro , Lutsey, Pamela L , Shah, Amil , Inciardi, Riccardo M. , Gottesman, Rebecca F. , Solomon, Scott David , Chen, Lin Y.

Mayo Clinic

European Journal of Neurology | November 21, 2024 | Volume: 32 | Issue: 1 | Pages: No page available

10.1111/ene.16549 | PMID 39569699 Get It

AbstractBackground and purposeLower left atrial (LA) function is associated with higher dementia risk and may be mechanistically linked through vascular brain injury, an established correlate for higher dementia risk. Using data from the Atherosclerosis Risk in Communities study, we assessed the cross‐sectional association between LA function and brain magnetic resonance imaging (MRI) markers of vascular brain injury.MethodsWe included 1488 participants who were free of prevalent dementia, stroke, or atrial fibrillation and who underwent a two‐dimensional echocardiogram and brain MRI in 2011–2013 (mean [± standard deviation] age 76 [± 5] years, 60% female, 27% Black). LA function measures (reservoir, conduit, contractile strain) were assessed in quartiles. Brain MRI measures included cerebral microbleeds, brain infarcts, and white matter hyperintensity (WMH) volume. Logistic regression was used for dichotomous outcomes. Linear regression was used for WMH volume.ResultsOverall, 343 (23%) and 344 participants (23%) had ≥1 cerebral microbleed or brain infarct. After multivariable adjustments, the lowest LA reservoir and conduit strain quartiles (vs. highest quartile) were associated with higher odds of the presence of ≥1 cerebral microbleed (odds ratios [95% confidence intervals] 1.78 [1.42–2.22] and 1.52 [1.22–1.90]). Compared to the highest quartile, participants in the lowest LA conduit strain quartile had 1.51 (95% confidence interval 1.22–1.88) times higher odds of having ≥1 brain infarct. Lower LA contractile strain was associated with lower odds of brain infarcts. No association with WMH volume was noted.ConclusionsWe found that LA reservoir and conduit strain were associated with cerebral microbleeds and brain infarcts. Lower LA function may be linked to dementia risk via vascular brain injury. Prospective studies are needed to confirm these findings.
Contraction of collagen gels seeded with tendon cells
Chen, M.-Y., Jeng, Lily, Sun, Y.-L., Zhao, C.-F., Zobitz, M. E., Moran, Steven L. , Amadio, Peter C. , An, K.-N.

Mayo Clinic

Biorheology: The Official Journal of the International Society of Biorheology | November 21, 2024 | Volume: 43 | Issue: 3-4 | Pages: 337-345

10.1177/0006355x2006043003004017 Get It

Knowledge of the adaptation of the soft tissue to mechanical factors and biomolecules would be essential to better understand the mechanism of tendon injury and to improve the outcome of tendon repair. The responses to these factors could be different for the distinct types of cells in the tendon: cells from the tendon sheath, fibroblasts from the epitenon surface, or fibroblasts from the internal endotenon. In this study, we examined the mechanical and histological characteristics of the rate of contraction of the collagen gel seeded with epitenon and endotenon fibroblasts. The rate of contraction and the mechanical property of the contracted construct depend on the gel concentration and also the treatment of TGF-β 1 .
Radiology-pathology correlation: Rosai–Dorfman disease
Benson, John C. , Pais, Alex B, Mark, Ian T. , Chen, John J. , Meyer, Frederic B., Giannini, Caterina, Tobin, William O, Benson, John , Mark, Ian , Chen, John J , Pais, Alex B, Tobin, W. Oliver , Hunt, Christopher H.

Mayo Clinic

The Neuroradiology Journal | November 20, 2024 | Volume: 38 | Issue: 3 | Pages: 299-303

10.1177/19714009241303077 | PMID 39567877 Get It

Rosai–Dorfman Disease (RDD), also known as sinus histiocytosis with massive lymphadenopathy, is a rare non-Langerhans cell histiocytic neoplasm. Although the disease classically presents as massive painless lymphadenopathy in young adults, RDD can also involve the central nervous system in some patients. CNS lesions, can cause headaches, neurologic deficits, and even neurologic deficits. The imaging appearance of CNS RDD typically mimics that of meningiomas: well-circumscribed dural-based lesions that often have dural tails. However, some imaging clues also exist that might help a radiologist recognize RDD, even before histopathologic confirmation. This radiology-pathology report of a patient with CNS RDD highlights the most pertinent clinical, imaging, and pathologic features of CNS RDD, and discusses what the neuroradiologist needs to know about the disease.
The atypical faces of optic neuritis: neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease
Poonja, Sabrina, Chen, John J., Chen, John J. , Chen, John J , Poonja, Sabrina , Rattanathamsakul, Natthapon

Mayo Clinic

Current Opinion in Neurology | November 20, 2024 | Volume: 38 | Issue: 1 | Pages: 96-104

10.1097/wco.0000000000001335 | PMID 39564614 Get It

Purpose of review The purpose of this article is to provide a review of neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), with a focus on what renders optic neuritis “atypical” in these two conditions. Clinical features, diagnostic criteria, and epidemiology are outlined. Acute treatments for optic neuritis, as well as immunotherapy for NMOSD and MOGAD are discussed. Recent findings Updates in NMOSD and MOGAD are highlighted, with an emphasis on novel work including the new 2023 MOGAD diagnostic criteria, our evolving understanding on the epidemiology of these conditions, and recently FDA-approved NMOSD treatments. Pipeline therapies are also discussed. Summary A thorough history and examination, supported by ancillary testing, continues to be the mainstay of optic neuritis diagnosis. Stratifying typical versus atypical optic neuritis is paramount. Within the atypical category, NMOSD and MOGAD are important considerations. Clues can point towards these diagnoses and guide steps for treatment, which is increasingly becoming targeted to individual diseases, as the pathophysiology is different for these disorders.
Neuro-Ophthalmic Literature Review
Chen, John J. , Hung, Wei-Che , Jindahra, Panitha , Vaphiades, Michael S., Zhang, Xiaojun , Chen, John J , Mak, Andrew C. Y. , McClelland, Collin M. , Verma, Rashmi , Xie, Jim Shenchu

Mayo Clinic

Neuro-Ophthalmology | November 19, 2024 | Volume: 48 | Issue: 6 | Pages: 464-471

10.1080/01658107.2024.2408954 Get It

Effects of eplontersen on symptoms of autonomic neuropathy in hereditary transthyretin-mediated amyloidosis: secondary analysis from the NEURO-TTRansform trial
Wixner, Jonas, Adams, David , Polydefkis, Michael , Conceição, Isabel , Dyck, P. James B. , Folkvaljon, Folke, Zhou, Wunan , Chen, Jersey , Viney, Nicholas J. , Kwoh, T. Jesse, Coelho, Teresa , Adams, David , Conceição, Isabel , Gillmore, Julian D , Berk, John L. , Attarian, Shahram , Gillmore, Julian D. , Waddington‐Cruz, Márcia

Mayo Clinic

Amyloid | November 18, 2024 | Volume: 32 | Issue: 1 | Pages: 29-38

10.1080/13506129.2024.2427290 | PMID 39552152 Get It